DAYBUE

This brand name is authorized in United States.

Active ingredients

The drug DAYBUE contains one active pharmaceutical ingredient (API):

`1`	Trofinetide UNII `Z2ME8F52QL` - TROFINETIDE
	Trofinetide is indicated for the treatment of Rett syndrome. The mechanism by which trofinetide exerts its therapeutic effects is unknown.
	Read more about Trofinetide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DAYBUE Oral solution	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
US	FDA, National Drug Code	63090-660

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.